Related Experiment Video
Updated: Mar 3, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Microglia Endocytose Amyloid β Through the Binding of Transglutaminase 2 and Milk Fat Globule EGF Factor 8 Protein
Kenji Kawabe1, Katsura Takano2, Mitsuaki Moriyama1
1Laboratory of Integrative Physiology in Veterinary Sciences, Osaka Prefecture University, 1-58, Rinku-Ourai Kita, Izumisano, Osaka, 598-8531, Japan.
Abstract:
Activation of glial cells has been observed in neurodegenerative diseases including Alzheimer's disease (AD). Aggregation of amyloid β (Aβ) is profusely observed as characteristic pathology in AD brain. In our previous study using microglial cell line BV-2, tissue-type transglutaminase (TG2) was found to be involved in phagocytosis (Kawabe et al., in Neuroimmunomodulation 22(4):243-249, 2015; Kawabe et al., Neurochem Res 2017). In the present study, we examined whether TG2 and milk fat globule EGF factor 8 protein (MFG-E8), an adaptor protein promotes macrophage to engulf apoptotic cells, were involved in Aβ endocytosis. When the neuronal/glial mixed culture was stimulated freshly prepared Aβ1-42 for 3 days, the incorporation of Aβ was observed by immunofluorescence staining technique in Iba-1-positive microglia. Cystamine, a broad competitive inhibitor of TGs, suppressed it. When aggregated Aβ was added to the mixed culture, the immunoreactivity of MFG-E8 surrounding Aβ was observed, and then followed by microglial endocytosis. Using western blotting technique, MFG-E8 was detected in cell lysate of astrocyte culture, and was also detected in the medium. When microglia culture was incubated with astrocyte conditioned medium, MFG-E8 levels in microglia tended to increase. It is likely that microglia might utilize MFG-E8 released from astrocytes as well as that expressed in themselves in order to endocytose Aβ aggregation. Furthermore, we confirmed that MFG-E8 could bind with TG2 in microglia culture by immunoprecipitate technique. These results suggest that microglia might uptake Aβ as a complex of aggregated Aβ/MFG-E8/TG2.
Insights
Microglia uptake amyloid beta (Aβ) aggregates by utilizing milk fat globule EGF factor 8 protein (MFG-E8) and tissue-type transglutaminase (TG2). This interaction facilitates Aβ clearance in Alzheimer's disease models.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Glial cell activation is implicated in neurodegenerative diseases like Alzheimer's disease (AD).
- Amyloid beta (Aβ) aggregation is a hallmark pathology in AD brains.
- Tissue-type transglutaminase (TG2) is involved in microglial phagocytosis.
Purpose of the Study:
- To investigate the roles of TG2 and milk fat globule EGF factor 8 protein (MFG-E8) in Aβ endocytosis by microglia.
- To elucidate the mechanism of Aβ clearance in AD.
Main Methods:
- Neuronal/glial mixed cultures and microglia cultures were used.
- Amyloid beta (Aβ)1-42 stimulation and aggregated Aβ treatment.
- Immunofluorescence staining, western blotting, and immunoprecipitation techniques were employed.
- Cystamine, a TG inhibitor, was used to assess TG2's role.
Main Results:
- Microglia were observed to incorporate Aβ, which was suppressed by cystamine.
- MFG-E8 immunoreactivity surrounded aggregated Aβ, preceding microglial endocytosis.
- MFG-E8 was detected in astrocytes and their conditioned medium, increasing in microglia.
- MFG-E8 was found to bind with TG2 in microglia.
Conclusions:
- Microglia likely use both endogenous and astrocyte-derived MFG-E8 for Aβ endocytosis.
- Aβ uptake may occur as a complex of aggregated Aβ/MFG-E8/TG2.
- This study reveals a novel mechanism for Aβ clearance involving MFG-E8 and TG2 in microglia.

